Sign in

CIK 0001512762

  • Accelerated filer
  • Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273615821
Phone
+1 650-649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 4 Grant or award Chief Scientific Officer acquired 40,000 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 40,000 shares (grant or award)
  3. 4 Shares withheld for taxes Chief Scientific Officer gave up 7,204 shares (to pay taxes)
  4. 4 Shares withheld for taxes McMichael Bryan J gave up 1,699 shares (to pay taxes)
  5. 4 Shares withheld for taxes President & CEO gave up 10,905 shares (to pay taxes)
  6. 4 Derivatives Options or other derivatives
  7. 4 Shares withheld for taxes Chief Scientific Officer gave up 5,437 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Financial Officer gave up 5,437 shares (to pay taxes)
  9. 4 Gift President & CEO gave 4,000 shares (gift)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Shares withheld for taxes Chief Financial Officer gave up 3,458 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Scientific Officer gave up 3,458 shares (to pay taxes)
  19. 4 Grant or award Director acquired 40,000 shares (grant or award)
  20. 4/A Derivatives Options or other derivatives

Page 5 of 20 · 399 filings